Advancing Digital Measures Towards Scalable Clinical Impact
Join us for the Ametris Digital Data Summit 2027! Now in its fifth year, ADDS is heading to Atlanta once again to facilitate easier access and expanded space and support our growing community. ADDS is a one-of-a-kind scientific conference advancing the adoption of wearable digital health technologies (DHTs) in clinical research by bringing together a multidisciplinary group of digital health leaders for expert-led presentations and collaborative discussions.
We are pleased to announce the ADDS 2027 annual meeting will be held February 8-10 in Atlanta, Georgia.
ActiGraph will host a scientific poster session during the ADDS Atlanta 2026 event featuring original research that involves the use of wearable digital health technologies (DHTs). This is an exciting opportunity for researchers to share their work with digital health leaders across academia and the drug development industry!
We invite you to submit your abstract for consideration to be included in the poster session no later than Sunday, October 26. Applicants will be eligible to apply for a travel award based on scientific merit and financial need.
It's nice to have a conference that has a very specific focus, because we can dive much deeper into that and really get into the meat of the data. You can get into a much deeper understanding of the particular topic as well as some of the advancements in the field.
Ariel Dowling, PhD
Head of Sensing and Measurement | Takeda
It's a perfect thing when you can come to a conference, and you can meet people and immediately realize that you have things in common and can help each other; to meet other people who are really in different fields, but experiencing some of the same issues and develop potential collaborations across the board.
Johathan Soslow
Pediatric Cardiologist | Vanderbuilt University
An event like this brings talent that you normally are not exposed to, and as you see these presentations, you're shocked as to how much innovation is out there.
Peter Fernandes
CEO | Bellerophon Therapeutics
I think a lot of us do research in the technology and how we can apply it to our specific research interests or populations, but learning how to cross those boundaries between clinical populations is important.
Jennifer Schrack
Professor of Epidemiology and Medicine | Johns Hopkins Bloomberg School of Public Health
